Pasar al contenido principal

UNA PERSPECTIVA GLOBAL DE LAS ENFERMEDADES NEUMOCOCICAS Y LA RESISTENCIA EN TIEMPOS DE PANDEMIA POR COVID-19 Y VACUNACION UNIVERSAL EN PEDIATRIA.

PI21/01000

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IDIBELL
Centro realización INSTITUTO DE INVESTIGACION BIOMEDICA DE BELLVITGE (IDIBELL)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A New Integrative and Mobilizable Element Is a Major Contributor to Tetracycline Resistance in Streptococcus dysgalactiae subsp. equisimilis

  • López de Egea, Guillem|||0000-0002-4196-7627
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Guédon, Gérard|||0000-0002-5289-3803
  • Lao, Julie
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Fernández-Delgado, Lucía|||0000-0001-8815-0967
  • Chiapello, Hélène
  • Lacroix, Thomas|||0000-0002-6708-5809
  • Domínguez, María Ángeles
  • Leblond-Bourget, Nathalie|||0000-0001-5739-1370
  • Ardanuy, Carmen|||0000-0003-0225-607X
Tetracycline resistance in streptococci is mainly due to ribosomal protection mediated by the tet (M) gene that is usually located in the integrative and conjugative elements (ICEs) of the Tn 916 -family. In this study, we analyzed the genes involved in tetracycline resistance and the associated mobile genetic elements (MGEs) in Streptococcus dysgalactiae subsp. equisimilis (SDSE) causing invasive disease. SDSE resistant to tetracycline collected from 2012 to 2019 in a single hospital and from 2018 in three other hospitals were analyzed by whole genome sequencing. Out of a total of 84 SDSE isolates, 24 (28.5%) were resistant to tetracycline due to the presence of tet (M) (n = 22), tet (W) (n = 1), or tet (L) plus tet (W) (n = 1). The tet (M) genes were found in the ICEs of the Tn 916 -family (n = 10) and in a new integrative and mobilizable element (IME; n = 12). Phylogenetic analysis showed a higher genetic diversity among the strains carrying Tn 916 than those having the new IME, which were closely related, and all belonged to CC15. In conclusion, tetracycline resistance in SDSE is mostly due to the tet (M) gene associated with ICEs belonging to the Tn 916 -family and a new IME. This new IME is a major cause of tetracycline resistance in invasive Streptococcus dysgalactiae subsp. equisimilis in our settings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evolution of invasive pneumococcal disease by serotype 3 in adults, a Spanish three-decade retrospective study

  • Calvo-Silveria, Sara|||0000-0001-8448-6017
  • Gonzalez Diaz, Aida|||0000-0002-8326-1307
  • Grau, Inmaculada
  • Marimón, José María|||0000-0002-2787-7094
  • Cercenado, Emilia|||0000-0002-5279-3773
  • Quesada, Maria Dolores|||0000-0001-8360-3787
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Larrosa, María Nieves|||0000-0001-8808-0233
  • Yuste, José|||0000-0001-7996-0837
  • Berbel, Dàmaris|||0000-0002-3689-3360
  • Alonso, Marta
  • Tubau, Fe|||0000-0002-6416-6451
  • Belman, Sophie
  • Cadenas-Jiménez, Irene|||0009-0003-0633-5784
  • Martín-Galiano, Antonio J.|||0000-0002-6662-329X
  • Domínguez, M.Ángeles
  • Marti, Sara|||0000-0002-0405-2305
  • Liñares Louzao, Josefina|||0000-0002-0855-6623
  • Pallarés, Román|||0000-0003-3262-8508
  • Càmara, Jordi|||0000-0002-0817-0931
  • Ardanuy, Carmen|||0000-0003-0225-607X
Background: Invasive pneumococcal disease due to serotype 3 (S3-IPD) is associated with high mortality rates and long-term adverse effects. The introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the Spanish paediatric immunisation programme has not led to a decrease in the adult S3-IPD. We aimed to analyse the incidence, clinical characteristics and genomics of S3-IPD in adults in Spain. Methods: Adult IPD episodes hospitalized in a Southern Barcelona hospital were prospectively collected (1994-2020). For genomic comparison, S3-IPD isolates from six Spanish hospitals (2008-2020) and historical isolates (1989-1993) were analysed by WGS (Illumina and/or MinION). Findings: From 1994 to 2020, 270 S3-IPD episodes were detected. When comparing pre-PCV (1994-2001) and late-PCV13 (2016-2020) periods, only modest changes in S3-IPD were observed (from 1.58 to 1.28 episodes per 100,000 inhabitants year). In this period, the incidence of the two main lineages shifted from 0.38 to 0.67 (CC180-GPSC12) and from 1.18 to 0.55 (CC260-GPSC83). The overall 30-day mortality remained high (24.1%), though a decrease was observed between the pre-PCV (32.4%; 95.0% CI, 22.0-45.0) and the late-PCV13 period (16.7%; 95.0% CI, 7.5-32.0) (p = 0.06). At the same time, comorbidities increased from 77.3% (95.0% CI, 65.0-86.0) to 85.7% (95.0% CI, 71.0-94.0) (p = 0.69). There were no differences in clinical characteristics or 30-day mortality between the two S3 lineages. Although both lineages were genetically homogeneous, the CC180-GPSC12 lineage presented a higher SNP density, a more open pan-genome, and a major presence of prophages and mobile genetic elements carrying resistance genes. Interpretation: Adult S3-IPD remained stable in our area over the study period despite PCV13 introduction in children. However, a clonal shift was observed. The decrease in mortality rates and the increase in comorbidities suggest a change in clinical management and overall population characteristics. The low genetic variability and absence of clinical differences between lineages highlight the role of the S3 capsule in the disease severity. Funding: This study has been funded by Instituto de Salud Carlos III (ISCIII) "PI18/00339", "PI21/01000", "INT22/00096", "FI22/00279", CIBER "CIBERES-CB06/06/0037", "CIBERINFEC-CB21/13/00009" and MSD grant "IISP 60168".